Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.4K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.4K
Clinical Trials01:16

Clinical Trials

10.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.2K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Statistical Significance01:50

Statistical Significance

21.1K
Once data is collected from both the experimental and the control groups, a statistical analysis is conducted to find out if there are meaningful differences between the two groups. A statistical analysis determines how likely any difference found is due to chance (and thus not meaningful). In psychology, group differences are considered meaningful, or significant, if the odds that these differences occurred by chance alone are 5 percent or less. Stated another way, if we repeated this...
21.1K
Probability in Statistics01:14

Probability in Statistics

22.2K
Probability is the likelihood of an event occurring. The term event is defined as a collection of results of a procedure. An event is a simple event when an outcome cannot be divided into simpler parts.
An example of a simple event is a coin toss. The result of a coin toss is either a head or a tail. Here, head and tail are two simple events. These two simple events make up the sample space. Further, the probability of an event occurring falls within the range of 0 to 1. The probability of an...
22.2K
Lattice Centering and Coordination Number02:33

Lattice Centering and Coordination Number

11.4K
The structure of a crystalline solid, whether a metal or not, is best described by considering its simplest repeating unit, which is referred to as its unit cell. The unit cell consists of lattice points that represent the locations of atoms or ions. The entire structure then consists of this unit cell repeating in three dimensions. The three different types of unit cells present in the cubic lattice are illustrated in Figure 1.
Types of Unit Cells
Imagine taking a large number of identical...
11.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Dana-Farber CISNET Model for Breast Cancer Screening Strategies: An Update.

Medical decision making : an international journal of the Society for Medical Decision Making·2018
Same author

Sex Differences in Age at Primary Melanoma Diagnosis in a Population-Based Analysis (US Surveillance, Epidemiology, and End Results, 2005-2011).

The Journal of investigative dermatology·2016
Same author

Modeling the impact of population screening on breast cancer mortality in the United States.

Breast (Edinburgh, Scotland)·2011
Same author

Effect of screening mammography on breast-cancer mortality in Norway.

The New England journal of medicine·2010
Same author

Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.

Annals of internal medicine·2009
Same author

Mortality modeling of early detection programs.

Biometrics·2007
Same journal

Inference on summaries of a model-agnostic longitudinal variable importance trajectory with application to suicide prevention.

The annals of applied statistics·2026
Same journal

A NOVEL BAYESIAN FRAMEWORK UNCOVERING BRAIN CONNECTIVITY-TO-SHAPE RELATIONSHIP IN PRECLINICAL ALZHEIMER'S DISEASE.

The annals of applied statistics·2026
Same journal

EVALUATING MULTIPLEX DIAGNOSTIC TEST USING PARTIALLY ORDERED BAYES CLASSIFIER.

The annals of applied statistics·2026
Same journal

BRIDGING THE GAP: ENHANCING THE GENERALIZABILITY OF EPIGENETIC CLOCKS THROUGH TRANSFER LEARNING.

The annals of applied statistics·2026
Same journal

TREATMENT EFFECT HETEROGENEITY AND IMPORTANCE MEASURES FOR MULTIVARIATE CONTINUOUS TREATMENTS.

The annals of applied statistics·2026
Same journal

FEDERATED LEARNING OF ROBUST INDIVIDUALIZED DECISION RULES WITH APPLICATION TO HETEROGENEOUS MULTIHOSPITAL SEPSIS POPULATION.

The annals of applied statistics·2026
See all related articles

Related Experiment Video

Updated: Jan 20, 2026

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.5K

MULTI-CENTER CLINICAL TRIALS: RANDOMIZATION AND ANCILLARY STATISTICS.

L U Zheng1, Marvin Zelen2

  • 1DEPARTMENT OF BIOSTATISTICS HARVARD SCHOOL OF PUBLIC HEALTH 655 HUNTINGTON AVE., BOSTON, MA 02115.

The Annals of Applied Statistics
|August 22, 2019
PubMed
Summary
This summary is machine-generated.

This study introduces design-based methods for analyzing multi-center randomized clinical trials, improving statistical power by incorporating trial design features. These novel approaches enhance the analysis of complex clinical trial data.

Keywords:
design based analysesmulti-center trialspermuted blocks designrandomization

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

Related Experiment Videos

Last Updated: Jan 20, 2026

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
03:26

Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain

Published on: March 8, 2024

3.5K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology
  • Statistical Inference

Background:

  • Current statistical analyses for multi-center randomized clinical trials often rely on model-based approaches.
  • These model-based methods frequently overlook the inherent randomization process and trial design features, such as variations between study centers.
  • Ignoring center effects and trial design can lead to suboptimal statistical power and potentially biased inferences.

Purpose of the Study:

  • To develop and investigate novel analysis methods for multi-center randomized clinical trials that are based on the trial's randomization process.
  • To provide an alternative to model-based analyses by developing design-based methods that explicitly incorporate trial design elements like study centers.
  • To enhance the statistical power and robustness of clinical trial analyses.

Main Methods:

  • Developed design-based statistical methods for analyzing multi-center randomized clinical trials.
  • Utilized conditioning on ancillary statistics within the sample space generated by the randomization process.
  • Extended the design-based methods to accommodate group sequential trial designs.

Main Results:

  • The developed design-based methods effectively incorporate study centers and other trial design features into the analysis.
  • A significant increase in statistical power was observed when analyzing trials with center variation using these new methods.
  • The methods demonstrated similar power increases when applied to group sequential clinical trials.

Conclusions:

  • Design-based methods offer a powerful alternative to traditional model-based analyses for multi-center randomized clinical trials.
  • Incorporating trial design features, such as center effects, through design-based approaches leads to improved statistical power.
  • These methods provide a more robust framework for inference in complex clinical trial settings, including group sequential designs.